Search

everythinglearnresearchcommunity

for

Search:↓

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Immune cells affect hair growth and could lead to new hair loss treatments.

Stem cells are key for hair follicle recovery.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Hair loss can be an early sign of HIV infection.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

People with HIV and low T cell counts have more hair and scalp problems.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

FoxN1 overexpression in young mice harms immune cell and skin development.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.